Trump Signs Deal With Company in Effort Shift Drug Manufacturing to US: New York Times
1 sourceUpdated May 19, 2020
The United States will announce on Tuesday that it has signed a $354 million contract with a company to make generic medicines and pharmaceutical ingredients in the country needed to treat COVID-19, the New York Times…
Claim check
What each side asserts, disputes — or leaves out entirely.
Where do you land?
Whose framing of this story rings truest to you?
Sponsored
Coverage
Comments
Ask this story anything:
Free account · your comment posts right after signup
Sponsored